Dasminapant CAS No.1570231-89-8
Dasminapant CAS No.1570231-89-8
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-1939 | 1mg | 620.00 | + Add to cart |
|
| R-R-1939 | 2mg | 1100.00 | + Add to cart |
|
|
|
||||
Product description
Dasminapant (APG-1387)/CAS No.1570231-89-8, a bivalent SMAC mimetic and an IAP antagonist, blocks the activity of IAPs family proteins (XIAP, cIAP-1, cIAP-2, and ML-IAP). Dasminapant induces degradation of cIAP-1 and XIAP proteins, as well as caspase-3 activation and PARP cleavage, which leads to apoptosis. Dasminapant can be used for the research of hepatocellular carcinoma, ovarian cancer, and nasopharyngeal carcinoma.
| Appearance | N/A |
|---|---|
| Molecular Weight | 1157.40 |
| Purity | >90% |
| CAS | 1570231-89-8 |
| Formula | C60H72N10O10S2 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Dasminapant CAS No.1570231-89-8
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


